tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market
Advertisement

Crescent Biopharma (CBIO) Cash flow

Compare
988 Followers

Crescent Biopharma Cash Flow

CBIO's free cash flow for Q2 2025 was $5.08B. For the 2025 fiscal year, CBIO's free cash flow was decreased by $15.43M and operating cash flow was $5.08B. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -31.10M$ -46.46M$ -57.49M$ -39.24M$ -51.98M
Investing Cash Flow
$ 20.03K$ -84.19K$ -14.94K$ -68.51K$ -144.93K
Financing Cash Flow
$ 5.40K$ 4.16M$ 10.72M$ 18.14M$ 412.91K
End Cash Position
$ 10.72M$ 47.87M$ 90.25M$ 137.04M$ 158.20M
Free Cash Flow
$ -31.11M$ -46.54M$ -57.50M$ -39.31M$ -52.13M
Currency in USD

Crescent Biopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis